November 1, 2013

Teva Pharmaceutical Industries had $5.1 billion in sales and $711 million in profits in third-quarter 2013, the Israeli drug maker said.

October 31, 2013

Actavis is seeking Food and Drug Administration approval for a generic drug used to treat acne, triggering a lawsuit in a federal court from the maker of the branded version, the company said Thursday.

October 31, 2013

AmerisourceBergen announced on Thursday that fourth quarter revenue rose 28.3% as it gains “strong momentum” heading into fiscal 2014.

October 31, 2013

Brush Buddies has introduced the new Soniclean Pro available in 5000, 3000 and 2000 models.

October 31, 2013

Cardinal Health had sales of $24.5 billion and profits of $339 million in first quarter 2014, the company said.

October 31, 2013

A new book from a trade group representing makers of dietary supplements details the laws and regulations that govern the industry.

October 31, 2013

As part of its philanthropic mission, the CVS Caremark Charity Classic is hosting a series of golf clinics for veterans of all abilities.

October 31, 2013

The Food and Drug Administration is using long-term strategies to address drug shortages when they appear and requiring manufacturers to notify the agency if a shortage is at risk of happening, under a new plan announced Thursday.

October 31, 2013

Earlier this year, the Food and Drug Administration approved a new drug for treating cystic fibrosis for patients who have a specific genetic mutation, but that also treats the underlying cause of the disease rather than the disease itself.

October 31, 2013

Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze gel.

October 31, 2013

Insource Healthcare Solutions is adding wall-mounted and cart-mounted video systems at the hospitals it operates in upstate New York and Pennsylvania in order to allow for telehealth services and cut costs.

October 31, 2013

Mylan experienced a slight dip in sales in its third quarter, due primarily to fluctuating currency values, the generic drug maker said Thursday.

October 31, 2013

New York City Council voted on Wednesday to hike the minimum age for buying cigarettes from 18 years to 21 years.

October 31, 2013

Proctor & Gamble will expand its partnership with the American Red Cross by joining the Disaster Responder Program.

October 31, 2013

Sales at Meijer's first store in Detroit have been "very encouraging," according to published reports.

October 31, 2013

A personalized medicine company said a new study justifies clinical use of pharmacogenomic testing to help predict patients' response to psychiatric medications and improve treatment outcomes.

October 31, 2013

NEW YORK — Revlon has named former Colomer Group executive Lorenzo Delpani as president and CEO, effective Nov. 1.

October 31, 2013

Rite Aid's same-store sales increased by 2.1% this month compared with October 2012, the retail pharmacy chain said Thursday, also issuing an estimate of the negative effects of Hurricane Sandy on its sales.

October 31, 2013

The "vast majority" of available mobile apps focused on health and wellness have limited functionality or evidence of value in advancing healthcare provision and outcomes, according to a new report by IMS Health.

October 31, 2013

Members of a Minnesota-based health insurer will have the opportunity to receive a $5 Target gift card when they visit one of the retailer's clinics for a flu vaccination.

October 31, 2013

Walmart U.S. president and CEO Bill Simon and Secretary of Commerce Penny Pritzker announced at the SelectUSA 2013 Investment Summit on Thursday that three suppliers have made new domestic manufacturing commitments that will create 385 jobs.

October 30, 2013

A division of inVentiv Health has acquired Catalina Marketing's medication adherence services subsidiary, inVentiv said Thursday.

October 30, 2013

A division of Kroger Co. has placed an initial order for Alkaline88, a bottled water brand produced using a proprietary electrolysis beverage process.

October 30, 2013

Jim Cramer, host of CNBC's "Mad Money," is still bullish on Rite Aid.